Valink Therapeutics closes $11.8M Pre-A financing round to advance its oncology pipeline, led by redalpine.
Amount Raised
$11.8 Million
Round Type
Pre-Series A
BostonBiotechnologyHealth CareTherapeuticsInvestors
Description
Valink Therapeutics Inc. announced the closing of a $11.8 million funding round to expand its oncology pipeline. The funding will enhance the development of bispecific antibody-drug conjugates and is aimed at improving patient outcomes in cancer treatment. The round was led by redalpine with participation from LongeVC and Oxford Science Enterprises
Who to call at Valink Therapeutics, and when
A new round usually means Valink Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Valink Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Valink Therapeutics, from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Valink Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Valink Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.